COVID-19 highlighted vulnerabilities in medical manufacturing supply chain: Fitch
Posted by
www.biotecnika.org
"We believe that over the longer term, govt may aim to source more key
pharmaceutical ingredients locally as opposed to the current heavy
reliance on China, and to a lesser degree India," it said. This
provides an opportunity for the Indian govt to escalate domestic
production of pharma ingredients to counteract an over-reliance on
Chinese imports now hampered by COVID-19 shutdowns.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/covid-19-highlighted-vulnerabilities-in-medical-manufacturing-supply-chain-fitch/articleshow/75315651.cms
Subscribe to:
Post Comments (Atom)
Post a Comment